Baylor College Team Discovers the Origin of Alpha-1 Antitrypsin Deficiency in Infants
source: pixabay.com

Baylor College Team Discovers the Origin of Alpha-1 Antitrypsin Deficiency in Infants

  A recent article in Science News highlighted a discovery by Richard Seifes, M.D. of Baylor College of Medicine.  Dr. Seifes has discovered the origin of a liver disease that…

Continue Reading Baylor College Team Discovers the Origin of Alpha-1 Antitrypsin Deficiency in Infants

Could TKIs Be Effective for Patients with Alzheimer’s, Parkinson’s, and Dementia?

What sort of treatments are available for patients with dementia and other neurodegenerative conditions? Are these treatments safe and effective? While these questions vary in answers, researchers are currently exploring…

Continue Reading Could TKIs Be Effective for Patients with Alzheimer’s, Parkinson’s, and Dementia?

New Test Developed to Better Assess the Efficacy of Spinocerebellar Ataxia Type 3 Therapies

Researchers at the Mayo Clinic have collaborated with the international community to develop a potential way to test for spinocerebellar ataxia type 3 (SCA3), also called Machado-Joseph Disease. Additionally, they…

Continue Reading New Test Developed to Better Assess the Efficacy of Spinocerebellar Ataxia Type 3 Therapies
Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases
source: pixabay.com

Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases

  According to a recent article in Business Wire, it is estimated that five million people in the United States over the age of sixty-five are coping with Alzheimer’s at…

Continue Reading Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases
Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete
source: pixabay.com

Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete

According to a story from BioSpace, the biopharmaceutical company Clene Nanomedicine, Inc., has recently announced that it has completed the process of enrollment patient participants in its upcoming phase 2…

Continue Reading Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete
Vektor Tests Generic Neupro Patch
Source: https://pixabay.com/en/band-aid-first-aids-injury-24298/

Vektor Tests Generic Neupro Patch

Have you ever heard of the Neupro patch? This transdermal delivery system directly delivers a dopamine agonist called rotigotine into the body. For patients with Parkinson's disease, restless legs syndrome,…

Continue Reading Vektor Tests Generic Neupro Patch
MJFF Supports First Study of Anle138b for Parkinson’s
source: pixabay.com

MJFF Supports First Study of Anle138b for Parkinson’s

  Recently, the Michael J. Fox Foundation (MJFF) awarded $1.4 million in funding for Modag, a drug developer whose solutions treat patients with neurodegenerative diseases. In fact, says Parkinson's News…

Continue Reading MJFF Supports First Study of Anle138b for Parkinson’s
An Observation of Differing and Overlapping Coping Mechanisms and Quality of Life Among Parkinson’s Patients
source: pixabay.com

An Observation of Differing and Overlapping Coping Mechanisms and Quality of Life Among Parkinson’s Patients

by Danielle Bradshaw from In The Cloud Copy A study was done to figure out how people with Parkinson’s disease coped with the illness in their day to day lives,…

Continue Reading An Observation of Differing and Overlapping Coping Mechanisms and Quality of Life Among Parkinson’s Patients
Clash With COVID: Pandemic Negatively Impacts Parkinson’s Disease Patients
source: pixabay.com

Clash With COVID: Pandemic Negatively Impacts Parkinson’s Disease Patients

by Danielle Bradshaw from In The Cloud Copy Information provided by the Michael J. Fox Foundation showed that the majority of patients that had Parkinson’s disease and also contracted COVID-19…

Continue Reading Clash With COVID: Pandemic Negatively Impacts Parkinson’s Disease Patients
Michael J. Fox Foundation Supports Bill to Ban Paraquat, a Chemical Linked to Parkinson’s Disease
https://pixabay.com/photos/herbicide-avignon-in-rice-field-587589/

Michael J. Fox Foundation Supports Bill to Ban Paraquat, a Chemical Linked to Parkinson’s Disease

  Nobody knows the exact cause of Parkinson's disease. However, many researchers believe that environmental triggers may play a factor. Now, the Michael J. Fox Foundation (MJFF) is encouraging American…

Continue Reading Michael J. Fox Foundation Supports Bill to Ban Paraquat, a Chemical Linked to Parkinson’s Disease